Ethisphere Names Lincoln Electric as One of the 2024 World’s Most Ethical Companies® for the Sixth Time
CLEVELAND, March 04, 2024 (GLOBE NEWSWIRE) — Lincoln Electric Holdings Inc., (NASDAQ: LECO) has received the 2024 World’s Most Ethical […]
Zevra Therapeutics Provides FDA Update on the PDUFA Action Date for Arimoclomol as a Treatment for Niemann-Pick Disease Type C
The new Prescription Drug User Fee Act (PDUFA) action date set by the FDA is September 21, 2024 CELEBRATION, Fla., […]
TSX News -
Wallbridge Commences First Phase of Drilling at Martiniere
TORONTO, March 04, 2024 (GLOBE NEWSWIRE) — Wallbridge Mining Company Limited (TSX: WM, OTCQX: WLBMF) (“Wallbridge” or the “Company”) today […]
TSX News -
Titan Medical to Report Year-End 2023 Financial Results on March 29, 2024
TORONTO, Ontario, March 04, 2024 (GLOBE NEWSWIRE) — Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF), announced […]
Labrador Gold Intersects 10.63g/t Au Over 5.9 Metres at Big Vein, Includes 46.72g/t Au Over 1 Meter
TORONTO, March 04, 2024 (GLOBE NEWSWIRE) — Labrador Gold Corp. (TSX.V:LAB | OTCQX:NKOSF | FNR: 2N6) (“LabGold” or the “Company”) […]
Bitcoin Well Announces Record Number of Signups to the Bitcoin Portal in February
EDMONTON, Alberta, March 04, 2024 (GLOBE NEWSWIRE) — Bitcoin Well Inc. (“Bitcoin Well” or the “Company”) (TSXV: BTCW; OTCQB: BCNWF), […]
MariMed’s Betty’s Eddies™ Introduces Ache Away Eddies PM For Those Who Chews A Pain-Free Night’s Sleep
NORWOOD, Mass., March 04, 2024 (GLOBE NEWSWIRE) — Betty’s Eddies™, the all-natural cannabis fruit chews handcrafted to fit a variety […]
Y-mAbs Appoints Oncology Executive Mary Tagliaferri, M.D. to its Board of Directors
NEW YORK, March 04, 2024 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical […]
Velociti and Dragonfly Energy Deliver an Immediate Return on Investment with Lithium Power Systems
NEW ORLEANS, March 04, 2024 (GLOBE NEWSWIRE) — Velociti Inc., a global provider of technology deployment, maintenance and integration solutions, […]
Indaptus Therapeutics Announces Positive Results from Second Cohort of Phase 1 Trial; Company Initiates Multi-Dose Cohort
• Positive data following completion of second cohort of Phase 1 trial of Decoy 20 leads independent Safety Review Committee […]
